CANADIAN PHARMA CAPITAL LIMITED

Company number 12736213

Date	Type	Description	View / Download
30 Mar 2021	GAZ2(A)	Final Gazette dissolved via voluntary strike-off	(1 page)
12 Jan 2021	GAZ1(A)	First Gazette notice for voluntary strike-off	(1 page)
05 Jan 2021	DS01	Application to strike the company off the register	(1 page)
23 Nov 2020	PSC01	Notification of Michael Stephen Johnson as a person with significant control on 21 November 2020	(2 pages)
23 Nov 2020	PSC07	Cessation of Tamer Mohammed Soliman as a person with significant control on 21 November 2020	(1 page)
23 Nov 2020	CH01	Director's details changed for Professor Michael Stephen Johnson on 23 November 2020	(2 pages)
21 Nov 2020	AP01	Appointment of Professor Michael Stephen Johnson as a director on 21 November 2020	(2 pages)
21 Nov 2020	SH01	Statement of capital following an allotment of shares on 21 November 2020 GBP 300	(3 pages)
09 Nov 2020	TM01	Termination of appointment of Guy Rothschild as a director on 5 November 2020	(1 page)
12 Aug 2020	TM01	Termination of appointment of Tamer Mohammed Soliman as a director on 12 August 2020	(1 page)
11 Aug 2020	AP01	Appointment of Mr Guy Rothschild as a director on 10 August 2020	(2 pages)
28 Jul 2020	AP01	Appointment of Mr Dominic Traynor as a director on 28 July 2020	(2 pages)
13 Jul 2020	NEWINC	Incorporation Statement of capital on 2020-07-13 GBP 30 MODEL ARTICLES ‐ Model articles adopted	(10 pages)